We joined the type 1 diabetes (T1D) community on a prehistoric expedition through years of diabetes innovation at the annual Children With Diabetes Friends for Life conference in Orlando, Fla. The theme, “Roaming with Dinosaurs, Advancing with Science,” brought together past and future progress in diabetes technology. We had a blast meeting attendees and highlighting our research in type 1 diabetes through interactive microscope displays. Thanks to everyone who connected with us and to Children with Diabetes for hosting a great event! #FFLOrlando2024 #T1D #DiabetesAwareness
Vertex Pharmaceuticals
Biotechnology Research
Boston, MA 373,370 followers
The Science of Possibility
About us
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.
- Website
-
https://global.vrtx.com/
External link for Vertex Pharmaceuticals
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Boston, MA
- Type
- Public Company
- Founded
- 1989
- Specialties
- cystic fibrosis, alpha-1 antitrypsin deficiency (AATD), APOL1-mediated kidney diseases, sickle cell disease, beta thalassemia, Duchenne muscular dystrophy, and type 1 diabetes mellitus
Locations
Employees at Vertex Pharmaceuticals
Updates
-
Exciting news! Forbes named Vertex to its America's Best Employers for Women 2024 list. 🌟 To deliver on our promise to patients, we bring together diverse teams and empower our employees to be their best selves. Women make up more than half of our workforce, underscoring our commitment to creating an inclusive environment where all employees can grow and thrive. Supporting Vertexians’ unique needs, we offer industry-leading benefits, career development opportunities, and foster community and belonging through our global employee resource networks. Interested in joining us? Visit https://lnkd.in/gsbYsvtF
-
-
We’re celebrating our incredible interns today on #NationalInternDay! These talented young professionals have joined us across the globe to advance our uncompromising commitment to patients. Thank you for being an integral part of our team! At Vertex, we offer a variety of internships and early career programs across all functions. Learn how to join us as a #VertexIntern today https://lnkd.in/e-Y2GPas
-
-
“It’s like acid is running through your body” — that’s how one person living with sickle cell disease (SCD) described the pain caused by this serious, life-limiting disease. At Vertex, we’re committed to the SCD community, using our understanding of the underlying cause of the disease, and our innovative research approach, in the hopes of improving the lives of people living with serious diseases. https://lnkd.in/eKaPg4Wj
-
We’re honored to earn a spot on this list for the second year in a row! Our talented team makes the impossible possible. And we’re here to support their professional journey — offering mentoring, career development opportunities and more. Thank you, Vertexians for making Vertex a great place to work!
These are the 100 Best Large Workplaces for Millennials. Employees at this year’s winning companies outperformed their peers in agility, productivity, and innovation—business metrics essential to AI success. Notably, innovation levels are a staggering 97% higher than at typical organizations. To determine the list, Fortune partnered with Great Place To Work US to analyze survey feedback representing employees from companies across the U.S. “These companies are thriving as a direct result not only of the trust young generations put in their leaders, but all generations,” says Michael C. Bush, CEO of Great Place To Work. The top companies include: ➡️ Cisco ➡️ Hilton ➡️ NVIDIA ➡️ East West Bank ➡️ Kimley-Horn 🔗 See the full 2024 list: https://lnkd.in/eKUTz4fX
-
Innovation is a buzzword we use often, but what does it mean? Hear more from ID&E Associate Director Jordan on how we can be innovative in our science. Visit https://lnkd.in/erUJ6K_g to learn more about the values that drive us and explore open roles.
-
At Vertex, curiosity fuels innovation. Meet Megan Billings, a design engineer at our research site in Warwick, Rhode Island. Megan’s team harnesses the power of diverse disciplines like data science, computer science, chemistry and more, to turn cutting-edge research into real results. From ocean diving to watchmaking, watch how our robotics team is pioneering new solutions to address the toughest drug discovery challenges. #VertexDayInTheLife
-
“I am out there, a sponge every day.” Discover what our scientist Varsha has to say about her curiosity for research and science. Visit https://lnkd.in/eWQNRpnr to learn more about the values that drive us and explore open roles.
-
The opening of our new office space in Brussels, Belgium is an important milestone as we scale for the future, advancing our mission to deliver transformative medicines for people living with serious diseases. We place patients at the center of everything we do, so we’re creating new spaces within the communities in which we work for our employees to share ideas, develop innovative ways of working, and deliver for patients.
-
#Breaking: The U.S. FDA has accepted the application and granted Priority Review for our fifth investigational CFTR modulator #CysticFibrosis. Learn more: https://lnkd.in/eNhEVnMF